Back to Search Start Over

Efficacy, tolerability, and safety of infliximab biosimilar in comparison to originator biologic and adalimumab in patients with Crohn disease.

Authors :
Kaniewska, Magdalena
Rosołowski, Mariusz
Rydzewska, Grażyna
Source :
Polish Archives of Internal Medicine; 2019, Vol. 129 Issue 7/8, p484-489, 6p
Publication Year :
2019

Details

Language :
English
ISSN :
00323772
Volume :
129
Issue :
7/8
Database :
Supplemental Index
Journal :
Polish Archives of Internal Medicine
Publication Type :
Academic Journal
Accession number :
138452318
Full Text :
https://doi.org/10.20452/pamw.14901